The Effect of Narrative Exposure Therapy Intervention on Post-traumatic Stress Dissorder and Personal Recovery in Refugees and Asylum Seekers of Sindiane Programme
SINDIANE
Single Center, Randomized, Comparative, Prospective Interventional Study Evaluating the Impact of Brief Psychotherapy by Narrative Exposure Therapy (NET) on the Reduction of Symptoms of Post Traumatic Stress Disorder in Refugee and Asylum Seeking Women in the Program SINDIANE in Marseille
1 other identifier
interventional
46
1 country
1
Brief Summary
Displaced people, like refugees or asylum seekers, have high rate of potentially traumatic events. PTSD is one of the most common psychiatric trouble in this population. It requires specialized support and psychosocial program. Narrative Exposure Therapy (NET), a german psychotherapy, was developed in the 2000 to specifically treat psycho-trauma in this population. It is brief, effective on complex trauma and can be delivered by trained non-caregivers. All published randomized studies have conclued that NET is effetive, but there are still insifficient numbers to make recomendations. To our knowledge, NET has never been tested in France. In Marseille, SINDIANE is a community support and program for refugees and asylum seekers. Many workshops led by peer workers are offered to increase empowerment of beneficiaries and hel them to recover. The development of a NET workshop would make it possible to combine community support and specific and validated psychotherapy. Through this study, the investigators hypothesize that tratment of PTSD with NET in the community-based SINDIANE program decrease symptoms of PTSD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 23, 2022
CompletedFirst Posted
Study publicly available on registry
June 7, 2022
CompletedStudy Start
First participant enrolled
November 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 23, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 23, 2024
CompletedAugust 9, 2024
August 1, 2024
11 months
May 23, 2022
August 7, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
PTSD symptoms measure by PCL5
The PCL-5 is a self reported score. The higher the score, the greater intensity of the symptoms of PTSD. It is validated in english and french with goof psychometric characteristic. The total score of the questionnaire is 80. The scale varies per question from 0 to 4: 0 = Not at all 1. = A little bit 2. = Moderately 3. = Quite a bit 4. = Extremely If the patient gets a 0, it means that he/she does not have this symptom of post-traumatic stress. On the contrary, the more the score increases and tends towards 4, the more the symptom will be present in the patient.
1 month post NET therapy
Secondary Outcomes (3)
Evolution of PCL5 score
3 months and 6 months
Psychiatric comorbidity intensity score RHS15
before the intervention, 1 month post therapy, 3 months and 6 months
EvExperience indicators intensity score (GSE)
before the intervention, 1 month post therapy, 3 months and 6 months
Study Arms (2)
Experimental group
EXPERIMENTALBeneficiaries of NET therapy + standard Sindiane program management.
Control group
NO INTERVENTIONBeneficiaries of the standard care of the Sindiane program.
Interventions
There are four NET sessions, each lasting thirty minutes and defined in advance on a weekly basis. The first session is the one where the person concerned will establish his/her "Life Line" and start his/her life story with the peer mediator. The second and third session will be the one where the person will continue his life story. Each session will begin with the mediator reading the story from the previous session, with the person concerned modifying the story if they wish. The fourth session will also start with the reading of the story from the previous session and will finish the story if necessary. It will also be the occasion to give the printed story to the person concerned at the end of the session and have it signed by the mediator and the patient. To prevent a possible risk of decompensation of the subject during the session, there will be a psychiatrist on site at the time of the NET to be available if the patient needs it.
Eligibility Criteria
You may qualify if:
- Woman over 18
- Refugee or asylum seeker (habing applied to OFFPRA or with a residence permit)
- Belonging to the SINDIANE community project
- Having been exposed to at least one traumatic event (according to the DSM 5 definition validated by a doctor)
- Having a PCL5 score greater than 23
- Agreeing to participate in the study with an informed consent signed by the subject after explanations given by the investigating psychiatrist
- Patient affiliated to a social security health care
- Patient able to read and write arabic or french
You may not qualify if:
- Be under the age of 18
- Be included in another intervention research
- Presence of severe mental retardation or dementia according to DSM5
- Persons benefiting from special protection : under article L3212-1 and L3213-1 of the Public Health Code
- Persons referred to in articles L1121-5 to L1121-8 of the CSP
- Existence of a high suicide risk assessed by the R.U.D.
- Patient subject to a compulsory care measure (Law n°2011-803 of july 5, 2011 relating to the rights and protection of persons subject to psychiatric care and the terms of care)
- Patient refusing to sign the consent or unable to receive the information necessary to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assistance Publique Hôpitaux Marseille
Marseille, Bouches-du-Rhône, 13354, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
François CREMIEUX
Assistance Publique Hôpitaux Marseille
- PRINCIPAL INVESTIGATOR
Clotilde IZABELLE, Dr
Assistance Publique Hôpitaux Marseille
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 23, 2022
First Posted
June 7, 2022
Study Start
November 22, 2022
Primary Completion
October 23, 2023
Study Completion
April 23, 2024
Last Updated
August 9, 2024
Record last verified: 2024-08